Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3hp5 | 52P | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.604 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.602 | |
| 3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.528 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.525 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.524 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.524 | |
| 3fkn | FKN | Mitogen-activated protein kinase 14 | / | 0.523 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.514 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.511 | |
| 2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.500 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.499 | |
| 2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.485 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.476 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.475 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.473 | |
| 3c5u | P41 | Mitogen-activated protein kinase 14 | / | 0.471 | |
| 3hng | 8ST | Vascular endothelial growth factor receptor 1 | 2.7.10.1 | 0.469 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.467 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.466 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.461 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.460 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.459 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.457 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.456 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.454 | |
| 3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.451 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.450 | |
| 1osv | CHC | Bile acid receptor | / | 0.449 | |
| 1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.449 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.449 | |
| 1hvy | D16 | Thymidylate synthase | 2.1.1.45 | 0.448 | |
| 2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.448 | |
| 3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.448 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3cuk | FAD | D-amino-acid oxidase | 1.4.3.3 | 0.447 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.447 | |
| 2ph5 | NAD | Homospermidine synthase | / | 0.446 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3qa2 | XNA | Ketohexokinase | / | 0.446 | |
| 3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.446 | |
| 4hfm | NAP | 2-alkenal reductase (NADP(+)-dependent) | / | 0.446 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.445 | |
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.445 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.445 | |
| 3lfb | Z87 | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.444 | |
| 4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.444 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.443 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3icr | COA | Coenzyme A disulfide reductase | / | 0.443 | |
| 3iqe | F42 | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.443 | |
| 4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 4g6h | NAI | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.443 | |
| 4s33 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 2fgk | ATP | Alpha-hemolysin translocation ATP-binding protein HlyB | / | 0.442 | |
| 3v01 | 3V0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.442 | |
| 3vhk | BPK | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
| 4c2u | ANP | DNA helicase | / | 0.442 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.441 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3v04 | V04 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.441 | |
| 4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
| 4icy | FAD | PgaE | / | 0.441 | |
| 2cdu | FAD | NADH oxidase | / | 0.440 | |
| 2zgz | GNP | Plasmid segregation protein ParM | / | 0.440 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 3fmw | FAD | Oxygenase | / | 0.440 | |
| 3mec | 65B | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
| 4ase | AV9 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 |